EQS-PVR: Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution
Source: EQS
EQS Voting Rights Announcement:
30.9.2024
Overview ☐ Notification made after deadline Caution: In case of violations of major holdings notification rules, please pay attention to Section 137 BörseG 2018 (Suspension of voting rights)
1. Issuer: 2. Reason for the notification: Event changing the breakdown of voting rights 3. Person subject to notification obligation 4. 5. Date on which the threshold was crossed or reached: 6. Total positions
Details 7. Notified details of the resulting situation:
8. Information in relation to the person subject to the notification obligation: ☒ Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer. ☐ Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:
9. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights.
10. Sonstige Kommentare: -
|
Language: | English |
Company: | |
Hovengasse 25 | |
2100 Korneuburg | |
Internet: | www.marinomed.com |
End of News |
|
1998825 30.09.2024 CET/CEST